Reassuring Data on Use of DAPT and AnticoagulationReassuring Data on Use of DAPT and Anticoagulation

For patients requiring triple therapy in the ISAR-TRIPLE study, the data suggest that stopping clopidogrel after six weeks won't reduce the bleeding risk, but it won't up the risk of ischemic events either. Heartwire
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news